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Abstract
Summary A country-specific FRAX model has been devel-
oped for the Ukraine to replace the Austrian model hitherto
used. Comparison of the Austrian and Ukrainian models indi-
cated that the former markedly overestimated fracture proba-
bility whilst correctly stratifying risk.
Introduction FRAX has been used to estimate osteoporotic
fracture risk since 2009. Rather than using a surrogate model,
the Austrian version of FRAX was adopted for clinical prac-
tice. Since then, data have become available on hip fracture
incidence in the Ukraine.
Methods The incidence of hip fracture was computed from three
regional estimates and used to construct a country-specific
FRAX model for the Ukraine. The model characteristics were
compared with those of the Austrian FRAX model, previously
used in Ukraine by using all combinations of six risk factors and
eight values of BMD (total number of combinations =512).
Results The relationship between the probabilities of a major
fracture derived from the two versions of FRAX indicated a
close correlation between the two estimates (r > 0.95). The
Ukrainian version, however, gave markedly lower probabili-
ties than the Austrian model at all ages. For a major osteopo-
rotic fracture, the median probability was lower by 25% at age
50 years and the difference increased with age. At the age of
60, 70 and 80 years, the median value was lower by 30, 53 and
65%, respectively. Similar findings were observed for men
and for hip fracture.
Conclusion The Ukrainian FRAX model should enhance ac-
curacy of determining fracture probability among the
Ukrainian population and help to guide decisions about treat-
ment. The study also indicates that the use of surrogate FRAX
models or models from other countries, whilst correctly strat-
ifying risk, may markedly over or underestimate the absolute
fracture probability.
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Introduction
FRAX® is a computer-based algorithm developed by the for-
mer World Health Organization Collaborating Centre for
Metabolic Bone Diseases and first released in 2008. This al-
gorithm calculates fracture probability from clinical risk fac-
tors in women and men [1, 2]. The output of FRAX is the 10-
year probability of a major osteoporotic fracture (hip, clinical
spine, humerus or wrist fracture) and the 10-year probability
of hip fracture. Probability is calculated from age, body mass
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index (BMI) and dichotomized risk factors comprising prior
fragility fracture, parental history of hip fracture, current to-
bacco smoking, long-term oral glucocorticoid use, rheumatoid
arthritis, other causes of secondary osteoporosis and excessive
alcohol consumption. Femoral neck BMD can be optionally
input to enhance fracture risk prediction [3].
The risk of hip fracture and probably of other osteoporotic
fractures varies significantly around the world [4]. The differ-
ence in incidence between countries is much greater than the
difference in incidence between sexes within a country.
Indeed, greater than tenfold differences in hip fracture inci-
dence have been reported in different countries. For this rea-
son, FRAX models are calibrated for each country dependent
on the epidemiology of death and fracture (most usually hip
fracture). To date, FRAXmodels are available for 63 countries
(http://www.shef.ac.uk/FRAX) covering more than 80% of
the world population [5].
All the required information to build a FRAX model is not
available in all countries. In such cases, the use of a surrogate
model has been proposed [6] using the death rate of the index
country and the fracture rate of a country thought to be similar
to the index country in terms of fracture risk. Examples in-
clude Sri Lanka, India [7, 8] and until recently, Armenia. The
Ukrainian Scientific Medical Centre on Osteoporosis
Problems (Kiev) has used FRAX to estimate the osteoporotic
fracture risk since 2009 [9]. Rather than using a surrogate
model, the Austrian version of FRAXwas adopted for clinical
practice [10]. Since then, data have become available on hip
fracture incidence in the Ukraine. The aims of the present
study were to develop the Ukrainian FRAX model according
to the age- and sex-specific hip fracture rates in Ukraine and to
compare this with the Austrian FRAXmodel currently recom-
mended for Ukraine.
Methods
The development and validation of FRAX have been exten-
sively described [1, 2]. The risk factors used were based on a
systematic series of meta-analyses of population based cohorts
worldwide and validated in independent cohorts with over 1
million patient-years of follow-up. The construct of the FRAX
model for Ukraine required the beta coefficients of risk factors
in the original FRAX model, and the incidence of hip fracture
and death for Ukraine. The death hazard for 2009 was taken
from the data base of the United Nations [11].
Cohorts
The risk of hip fracture was calculated from two studies at
three regional sites in Ukraine (Vinnitsa city (1997–2002),
STOP-Study (Uzhgorod city and Vinnitsa area, 2011–2012).
The results of these studies have been reported elsewhere [12,
13]. In brief, in the Vinnitsa city study, cases of hip fracture
were identified retrospectively over a 6-year period (from
01.01.1997 to 31.12.2002) in men and women aged 50 years
or more. The second study (Study of the prevalence of
Osteoporotic fractures in Ukrainian Population—STOP-
Study), organized by the Ukrainian Association of
Osteoporosis, gathered retrospective information over 2 years
(01.01.2011 to 31.12.2012) in two regions—Uzhhorod city
and Vinnitsa area excluding Vinnitsa city.
Ascertainment of incident fractures
All data were retrieved from multiple sources (the records of
the ambulance service, city and district hospitals and outpa-
tient departments). All instances of double-counting corre-
sponding to multiple admissions for the same fracture were
deleted before analysis. Cases were defined as patients (aged
40 years or more) who were identified with hip fracture
Fig. 1 Observed Ukrainian age- and gender-stratified incidence of hip
fracture (upper panel) and comparison of observed data (symbols) and 1-
year incidence rates derived from piecewise linear regression (lower
panel)
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(ICD10 code S72.0 [femoral neck], S72.1 [trochanter], S72.2
[subtrochanter]) irrespective of the level of trauma, but cases
associated with neoplasia were excluded. We excluded pa-
tients with a code S72.9 (unspecified site of femoral fracture)
except where a surgical procedure indicated surgery on the
hip. Patients who had sustained a hip fracture in the previous
year at the same site were excluded as were patients with
multiple admissions for the same fracture in the index year.
We included patients with a hip fracture, who used the ambu-
lance service but refused hospitalization and treatment later.
We included hip fracture cases irrespective of region or coun-
try of origin.
Cases were ascertained from the age of 40 years since this
is the lower age limit used in FRAX. Incidence rates were
estimated as the number of men and women in 5-year age
intervals with one hip fracture in the year divided by the
age- and sex-specific population of each catchment using gov-
ernment estimates for the same year. Data from the three re-
gional studies were amalgamated weighted by catchment pop-
ulation. For the purposes of FRAX, data were smoothed using
piecewise linear regression on log-transformed incidence rates
by age with a breakpoint at 67 years of age. Thereafter, the
exponent was included in the FRAX model so that risk could
be calculated at any specific age rather than in 5-year intervals.
Comparison of Ukrainian and Austrian FRAX models
For the purpose of comparing the Ukrainian and the Austrian
models, probabilities of a major osteoporotic fracture (hip,
clinical spine, forearm and humeral fractures) and of hip
Fig. 2 Comparison of 10-year
probability of a major
osteoporotic fracture using the
Austrian FRAX tool applied to
the Ukrainian female population
and the Ukrainian tool for
multiple clinical scenarios. The
diagonal dashed line shows the
line of identity
Table 1 Probability (%) of a
major osteoporotic fracture
(MOF) or a hip fracture (with
95% tolerance intervals; TI) in
women at the percentiles of the
probability distribution (Austrian
version) by age
Percentile r value
10 50 90
Age Austria Ukraine (95%TI) Austria Ukraine (95%TI) Austria Ukraine (95% TI)
MOF
50 8 6 (5–6) 20 15 (15–16) 49 38 (38–39) 0.998
60 10 6 (6–7) 23 16 (15–16) 51 36 (35–36) 0.997
70 13 5 (4–6) 30 14 (13–15) 65 35 (33–36) 0.983
80 19 5 (4–7) 43 15 (13–16) 76 40 (38–42) 0.953
Hip
50 0.4 0.2 (0.0–0.5) 4 3 (3–3) 31 24 (24–25) 0.999
60 0.7 0.3 (0.0–0.7) 5 3 (3–4) 29 19 (19–20) 0.999
70 2.3 0.6 (0.0–1.5) 12 5 (4–6) 51 24 (23–4) 0.987
80 6.3 1.4 (0.0–2.9) 28 9 (7–11) 71 32 (30–34) 0.956
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fracture alone, were computed in men and women at ages 50,
60, 70 and 80 years for all possible combinations of clinical
risk factors at BMD T-scores between 0 and −3.5 SD in 0.5
SD steps with a BMI set to 25 kg/m2 [14]. Thus, we consid-
ered all combinations of six risk factors and eight values of
BMD giving a total number of combinations of 512. Note that
this was not a population simulation, but an array of all pos-
sible combinations. The correlation between the Austrian and
Ukrainian fracture probabilities was examined by piecewise
linear regression with knots at probabilities of 50 and 70% for
the Austrian probabilities of a major osteoporotic fracture and
at 5 and 20% for hip fracture using the same model. The
reason for using knots at different probabilities for the two
outcomes was because of the difference in the distribution of
probabilities. Tabular data compared probabilities with the
two versions at the 10th, 50th (median) and 90th percentile
of the distribution of the Austrian model. Differences in the
Ukrainian version at these percentiles were expressed as 95%
tolerance intervals (TI).
In order to compare Ukrainian hip fracture probabilities
with adjacent countries with a FRAX model and Austria, the
remaining lifetime probability of hip fracture and major oste-
oporotic fracture from the age of 50 years was calculated for
men and women, as described by Kanis et al. [15, 16].
Results
Figure 1 shows 1-year age- and gender-stratified incidence
rates of hip fracture for the Ukraine from the three regional
studies, as well as the incidence of hip fractures, based on the
linear regression. Hip fracture incidence was lowest in patients
aged 40–54 years and increased progressively with age.
Below the age of 65 years, hip fracture incidence was higher
in men than in women but, above this age the incidence in-
creased more markedly in women compared to men.
Fracture probability
The relationship between the probabilities of a major
fracture derived from the two versions of FRAX is
shown for women aged 50 to 80 years in Fig. 2. At all
ages, there was a close correlation between the two es-
timates (r > 0.95). The Ukrainian version gave lower
probabilities than the Austrian model at all ages. The
median value was lower by 25% at the age 50 years
and the difference increased with age. At the age of
60, 70 and 80 years, the median value was lower by
30, 53 and 65%, respectively.
Table 2 Probability (%) of a
major osteoporotic fracture
(MOF) or a hip fracture (with
95% tolerance intervals; TI) in
men at the percentiles of the
probability distribution (Austrian
version) by age
Age Percentile r value
10 50 90
Austria Ukraine (95%TI) Austria Ukraine (95%TI) Austria Ukraine (95% TI)
MOF
50 7 4 (3–6) 19 12 (11–14) 53 36 (34–37) 0.997
60 8 4 (3–5) 19 11 (10–12) 46 26 (25–27) 0.996
70 9 3 (2–4) 22 9 (8–9) 49 22 (21–22) 0.988
80 12 3 (2–4) 28 9 (8–10) 57 24 (23–25) 0.975
Hip
50 0.7 0.3 (0.0–1.2) 6 4 (3–5) 40 26 (25–27) 0.998
60 1.1 0.5 (0.0–1.1) 6 3 (2–4) 31 17 (16–17) 0.997
70 2.6 0.6 (0.0–1.5) 12 5 (4–6) 42 18 (17–19) 0.989
80 5.7 0.9 (0.0–2.1) 21 7 (5–8) 54 21 (20–22) 0.975
Table 3 Ten-year probability of major osteoporotic fracture (MOF) and
hip fracture in men and women aged 65 years with a prior fragility
fracture. (Body mass index set to 25 g/m2)
Country Men Hip fracture Women Hip fracture
MOF MOF
Austria 9.7 2.5 17 4.3
Belarus 3.1 0.9 6.2 1.8
Hungary 6.2 1.6 12 3.1
Moldova 9.3 2.5 17 4.7
Poland 4.5 1.2 8.3 2.2
Romania 5.2 1.5 9.5 2.6
Russia 9.2 1.3 18 2.6
Slovakia 9.1 2.4 17 4.3
Ukraine 4.6 1.2 8.8 2.3
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In the case of hip fracture, there was also a close correlation
between the two estimates (r > 0.95) at all ages. The Ukrainian
version gave lower estimates than the Austrian model at all
ages and by a proportion that increased with age (Table 1). In
men, the effect of the revision was qualitatively similar to that
in women (Table 2).
The large disparities between Austrian and Ukrainian
models were reflected in differences in the lifetime probabil-
ities of a hip fracture from the age of 50 years. In Austria, this
was 19.6% in women and 8.2% in men. The equivalent prob-
abilities in Ukraine were 5.4 and 2.8%, respectively.
Discussion
In this study, we documented the incidence of hip fracture in the
Ukraine. The incidence of hip fracture was used to populate a
country-specific FRAX tool to compute the 10-year probabilities
of hip and major osteoporotic fracture. The new model can now
replace the Austrian model used since 2009. In brief, the
Ukrainian model provided substantially lower estimates of frac-
ture probability at all ages. Importantly, the country-specific
model had little impact on the categorization of risk, since the
revisions did not change the rank order of fracture probability. In
the clinical scenarios presented in this paper, the correlation co-
efficients between the Austrian and authentic versions for frac-
ture probability exceeded 0.95 at all ages and in men as well as
women. Thus, an individual at the 90th percentile of risk with the
Austrian tool would still be very close to the 90th percentile of
risk using the Ukrainian FRAX tool. For this reason, the conse-
quences of using country-specific tools reside in the absolute
number generated and not in the rank order of risk. The same
phenomenon has been observed in FRAX revisions [14]. This is
of little consequence to the management of patients or the inter-
pretation of clinical studies. There is a useful analogy with the
different DXA devices available, where a substantial difference
in femoral neck BMD is seen between Hologic and Lunar ma-
chines, but the T-score derived from these is more or less identi-
cal [17]. However, difficulties arise when fracture probabilities
are used in health economic analysis to inform practice guide-
lines or devise intervention thresholds.
It is evident that the use of the Austrian model grossly
overestimated FRAX probabilities in Ukraine. Where FRAX
models are not available for a specific country, the International
Society for Clinical Densitometry and International Osteoporosis
Foundation recommend the use of surrogate FRAX models
using the fracture risk of a neighbouring country together with
the death risk of the index country [6]. Ukraine, situated in
Eastern Europe, shares borders with the Russian Federation to
the east and north-east, and with Belarus towards the north-west
border. Hungary, Slovakia and Poland are to its west; Romania
andMoldova share its south-west border. A comparison of prob-
abilities of the Ukrainian model with the Austrian model is given
in Table 3 together with neighbouring counties. The probabilities
were lower than in neighbouring countries with Poland being the
closest. In view of the disparate results, the adoption of a surro-
gate country (rather than the entire Austrian model) might have
given equally misleading results.
Ideally, FRAX models should use fracture rates for the
whole country [4], whereas the present study sampled fracture
rates from three regions (two of 24 provinces) representing
only about 1% of the total population aged 40 years or more.
It is well established that there are regional variations in hip
fracture rates within countries [18–21]. Indeed, regional dif-
ferences in hip fracture incidence have been reported using
common methodology with the higher rates in urban commu-
nities in several countries [20–24] but, given the absence of
national registers, we had to rely on the regional estimates.
The situation is not unique and regional estimates have also
been used to create FRAX models for Brazil [25–30].
A limitation of the present study is that we were not able to
collect data on fracture at sites other than the hip. For this reason,
the FRAX model relied on hip fracture rates to estimate the
incidence of a major osteoporotic fracture. For this purpose, it
is assumed that the ratio of hip fracture incidence to other FRAX
outcomes (clinical spine, distal forearm and proximal humerus) is
the same in the index country as that documented in Sweden. The
ratios for Sweden were derived using national hip fracture data
for Sweden and data fromMalmo for the other fracture outcomes
[31]. Despite many studies that have examined the incidence of
fractures by age and sex, there are problems in defining the
pattern of fractures in different countries. The available evidence
indicates that the incidence of major fractures can be reasonably
predicted from the incidence of hip fracture [31–33].
With these caveats, a country-specific FRAXmodel has been
developed for the Ukraine which can now replace the Austrian
model hitherto used. This model should enhance accuracy of
determining fracture probability among the Ukrainian popula-
tion and help to guide decisions about treatment. The study also
indicates that the use of surrogate FRAXmodels or models from
other countries, whilst correctly stratifying risk, may markedly
over or underestimate the absolute fracture probability.
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